Ann: Positive IHL-675A in vivo results and FDA Pathway, page-76

This was great news today, pretty much as i had expected. Confirmation of the initial studies.
The excitement of getting emergency use approval will kick into the SP in a week or two.
I reckon all who want to jump on board have a window of maybe 2 weeks.
The potential to assist covid patients is massive, however, i digested the Ann a little differently..
on these results, comparing 675 to CBD(what everyone else is selling s..t loads of worldwide) is similar to a DVD to VHS player was.
Whilst 675 wont make CBD "redundant" it will offer patients an alternative more potent drug.
Kind of like, "do you want the base model" or the "deluxe"
This is where our drug could explode.
Remember Viagra? it was initially formulated to treat hypertension and angina and this drug ended up changing the world by chance.
Don't want to feel overconfident, but, all of us shareholders could well have a money tree growing in our backyards.